Objective. To determine the effects of osteogenic protein 1 (OP-1) on hyaluronan (HA), CD44, and aggrecan biosynthesis as well as the contribution of these molecules in promoting matrix assembly by human articular chondrocytes.Methods. Normal human chondrocytes were cultured with or without OP-1 treatment. Changes in the relative expression of messenger RNA (mRNA) for HA synthases 2 and 3 (HAS-2 and HAS-3), CD44, and aggrecan were determined by competitive quantitative reverse transcriptase-polymerase chain reaction. Accumulation of HA was characterized by indirect staining, CD44 by flow cytometry, and aggrecan biosynthesis by 35 SO 4 incorporation.Results. OP-1 stimulated the expression of HAS-2, CD44, and aggrecan mRNA in a time-dependent manner, resulting in increased expression of HA, CD44, and aggrecan. Prominent increases in HA-rich cellassociated matrices were also observed.Conclusion. OP-1 stimulates not only the synthesis of matrix macromolecules such as aggrecan, but also the synthesis of other molecules required for matrix retention, namely, HA and CD44.Osteoarthritis is a degenerative joint disease characterized by changes in the intrinsic metabolism of the resident cells of articular cartilage, the chondrocytes. Among the many alterations observed in osteoarthritic cartilage is a shift in the metabolism of chondrocytes toward catabolism (chondrocytic chondrolysis) over that of anabolism (matrix repair) (1). This metabolic imbalance results in the loss of extracellular matrix components from the cartilage, leading to tissue fatigue and eventually joint failure. Thus, one goal of matrix biologists is to develop and characterize reagents that work to reverse this metabolic imbalance and promote repair.Although reversing this metabolic imbalance is necessary, we have previously reported results which suggest that increased biosynthesis of matrix macromolecules alone may not be sufficient for optimal repair. That is, optimal repair requires not only the stimulation of matrix macromolecules, but also the presence of specific components responsible for the retention and assembly of matrix. Regrowth and assembly of cellassociated matrix surrounding articular chondrocytes in vitro requires the biosynthesis of hyaluronan (HA) in addition to aggrecan, as well as the expression of the HA receptor, CD44 (2,3). If either CD44 or HA is not present (or present in lower concentrations), matrix assembly does not occur. In organ cultures of cartilage tissue slices, antisense inhibition of CD44 leads to loss of matrix retention and sets off a cascade of chondrocytic chondrolysis (4). Thus, agents that will be useful in cartilage repair should induce or accelerate not only matrix production, but also biosynthesis of components required for matrix retention and assembly. Otherwise,